Bone marrow characteristics associated with changes in infarct size after STEMI: A biorepository evaluation from the CCTRN TIME trial

Circulation Research

Volumn 116, Issue 1, 2015, Pages 99-107

  Schutt, Robert C ^a   Trachtenberg, Barry H ^a   Cooke, John P ^a   Traverse, Jay H ^b   Henry, Timothy D ^c   Pepine, Carl J ^d   Willerson, James T ^e   Perin, Emerson C ^e   Ellis, Stephen G ^g   Zhao, David X M ^h   Bhatnagar, Aruni ⁱ   Johnstone, Brian H ^j   Lai, Dejian ^k   Resende, Micheline ^e   Ebert, Ray F ^l   Wu, Joseph C ^m   Sayre, Shelly L ^k   Orozco, Aaron ^e   Zierold, Claudia ^f   Simari, Robert D ⁿ   Moyé, Lem ^k   Cogle, Christopher R ^d   Taylor, Doris A ^e   more..

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e Texas Heart Institute CHI St Luke's Health   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ University of Louisville School of Medicine   (United States)

^j INDIANA UNIVERSITY   (United States)

^k UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^l NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^m STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

more..

Author keywords

acute myocardial infarction; adult stem cell; coronary circulation; regeneration

Indexed keywords

CD31 ANTIGEN; CD45 ANTIGEN;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW BIOPSY; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; COLONY FORMING CELL; COLONY FORMING UNIT HILL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; ENDOTHELIAL COLONY FORMING CELL; FEMALE; FLOW CYTOMETRY; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART EJECTION FRACTION; HEART INFARCTION SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; AGED; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; MYOCARDIAL INFARCTION; PHYSIOLOGY; PROCEDURES;

ADULT; AGED; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; COHORT STUDIES; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES;

EID: 84920852068     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.304710     Document Type: Article

References (42)

1. Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation. 2008;118:2057-2062. doi: 10.1161/CIRCULATIONAHA.108.784215.
2. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362:2155-2165. doi: 10.1056/NEJMoa0908610.
3. Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells. 2010;28:585-596. doi: 10.1002/stem.269.
4. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230-247.
5. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998;92:362-367.
6. Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Watt S, Martin-Rendon E. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2012;2:CD006536. doi: 10.1002/14651858. CD006536.pub3.
7. Bello D, Einhorn A, Kaushal R, Kenchaiah S, Raney A, Fieno D, Narula J, Goldberger J, Shivkumar K, Subacius H, Kadish A. Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease. Magn Reson Imaging. 2011;29:50-56. doi: 10.1016/j.mri.2010.03.031.
8. Traverse JH, Henry TD, Pepine CJ, et al; Cardiovascular Cell Therapy Research Network (CCTRN). Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA. 2012;308:2380-2389. doi: 10.1001/jama.2012.28726.
9. Zierold C, Carlson MA, Obodo UC, et al. Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale. Am Heart J. 2011;162:973-980.
10. Traverse JH, Henry TD, Vaughan DE, et al; Cardiovascular Cell Therapy Research Network (CCTRN). Rationale and design for TIME: a phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction. Am Heart J. 2009;158:356-363. doi: 10.1016/j.ahj.2009.06.009.
11. Gee AP, Richman S, Durett A, et al. Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience. Cytotherapy. 2010;12:684-691. doi: 10.3109/14653249.2010.487900.
12. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213-226.
13. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593-600. doi: 10.1056/NEJMoa022287.
14. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007;109:1801-1809. doi: 10.1182/blood-2006-08-043471.
15. Fan M, Chen W, Liu W, Du GQ, Jiang SL, Tian WC, Sun L, Li RK, Tian H. The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction. Rejuvenation Res. 2010;13:429-438. doi: 10.1089/rej.2009.0986.
16. Linthout SV, Spillmann F, Schultheiss HP, Tschöpe C. Effects of mesenchymal stromal cells on diabetic cardiomyopathy. Curr Pharm Des. 2011;17:3341-3347.
17. Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Circulation. 1993;88:2277-2283.
18. Pfeffer MA, Greaves SC, Arnold JM, Glynn RJ, LaMotte FS, Lee RT, Menapace FJ Jr, Rapaport E, Ridker PM, Rouleau JL, Solomon SD, Hennekens CH. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation. 1997;95:2643-2651.
19. Suzuki R, Fukuda N, Katakawa M, Tsunemi A, Tahira Y, Matsumoto T, Ueno T, Soma M. Effects of an angiotensin II receptor blocker on the impaired function of endothelial progenitor cells in patients with essential hypertension. Am J Hypertens. 2014;27:695-701. doi: 10.1093/ajh/hpt208.
20. Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis. 2006;187:423-432. doi: 10.1016/j. atherosclerosis.2005.10.009.
21. Baumann CI, Bailey AS, Li W, Ferkowicz MJ, Yoder MC, Fleming WH. PECAM-1 is expressed on hematopoietic stem cells throughout ontogeny and identifies a population of erythroid progenitors. Blood. 2004;104:1010-1016. doi: 10.1182/blood-2004-03-0989.
22. Newman PJ. The biology of PECAM-1. J Clinical Invest. 1997;99:3.
23. Lee CW, Hwang I, Park CS, Lee H, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Park SJ. Differences in intravascular ultrasound and histological findings in culprit coronary plaques between ST-segment elevation myocardial infarction and stable angina. J Thromb Thrombolysis. 2014;37:443-449. doi: 10.1007/s11239-013-0975-z.
24. Kim H, Cho HJ, Kim SW, Liu B, Choi YJ, Lee J, Sohn YD, Lee MY, Houge MA, Yoon YS. CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease. Circ Res. 2010;107:602-614. doi: 10.1161/CIRCRESAHA.110.218396.
25. Kawamoto A, Tkebuchava T, Yamaguchi J, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation. 2003;107:461-468.
26. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999-1007. doi: 10.1056/NEJMoa043814.
27. Massa M, Campanelli R, Bonetti E, Ferrario M, Marinoni B, Rosti V. Rapid and large increase of the frequency of circulating endothelial colony-forming cells (ECFCs) generating late outgrowth endothelial cells in patients with acute myocardial infarction. Exp Hematol. 2009;37:8-9. doi: 10.1016/j.exphem.2008.09.007.
28. Huang L, Hou D, Thompson MA, Baysden SE, Shelley WC, Ingram DA, March KL, Yoder MC. Acute myocardial infarction in swine rapidly and selectively releases highly proliferative endothelial colony forming cells (ECFCs) into circulation. Cell Transplant. 2007;16:887-897.
29. Meneveau N, Deschaseaux F, Séronde MF, Chopard R, Schiele F, Jehl J, Tiberghien P, Bassand JP, Kantelip JP, Davani S. Presence of endothelial colony-forming cells is associated with reduced microvascular obstruction limiting infarct size and left ventricular remodelling in patients with acute myocardial infarction. Basic Res Cardiol. 2011;106:1397-1410. doi: 10.1007/s00395-011-0220-x.
30. Rohde E, Bartmann C, Schallmoser K, Reinisch A, Lanzer G, Linkesch W, Guelly C, Strunk D. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells. 2007;25:1746-1752. doi: 10.1634/stemcells.2006-0833.
31. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. 2007;204:3037-3047. doi: 10.1084/jem.20070885.
32. Heil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M, Schaper W. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol. 2002;283:H2411-H2419. doi: 10.1152/ajpheart.01098.2001.
33. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 1998;101:40-50. doi: 10.1172/JCI119877.
34. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3:393-403.
35. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2:313-319. doi: 10.1016/j.stem.2008.03.002.
36. Heldman AW, DiFede DL, Fishman JE, et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA. 2014;311:62-73. doi: 10.1001/jama.2013.282909.
37. Klose K, Roy R, Brodarac A, Kurtz A, Ode A, Kang KS, Bieback K, Choi YH, Stamm C. Impact of heart failure on the behavior of human neonatal stem cells in vitro. J Transl Med. 2013;11:236. doi: 10.1186/1479-5876-11-236.
38. Neef K, Choi YH, Weichel A, Rahmanian PB, Liakopoulos OJ, Stamm C, Choi CY, Jacobshagen C, Wittwer T, Wahlers T. The influence of cardiovascular risk factors on bone marrow mesenchymal stromal cell fitness. Cytotherapy. 2012;14:670-678. doi: 10.3109/14653249.2012.663483.
39. Mouquet F, Pfister O, Jain M, Oikonomopoulos A, Ngoy S, Summer R, Fine A, Liao R. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res. 2005;97:1090-1092. doi: 10.1161/01.RES.0000194330.66545.f5.
40. Sheikh AY, Lin SA, Cao F, Cao Y, van der Bogt KE, Chu P, Chang CP, Contag CH, Robbins RC, Wu JC. Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells. 2007;25:2677-2684. doi: 10.1634/stemcells.2007-0041.
41. Wu Y, Ip JE, Huang J, Zhang L, Matsushita K, Liew CC, Pratt RE, Dzau VJ. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res. 2006;99:315-322. doi: 10.1161/01.RES.0000235986.35957.a3.
42. Masci PG, Bogaert J. Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI. Cardiovasc Diagn Ther. 2012;2:113-127. doi: 10.3978/j.issn.2223-3652.2012.04.06.